Lois La Grenade

1.6k total citations
20 papers, 937 citations indexed

About

Lois La Grenade is a scholar working on Pharmacology, Immunology and Dermatology. According to data from OpenAlex, Lois La Grenade has authored 20 papers receiving a total of 937 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 6 papers in Immunology and 5 papers in Dermatology. Recurrent topics in Lois La Grenade's work include T-cell and Retrovirus Studies (5 papers), Drug-Induced Adverse Reactions (5 papers) and Vector-Borne Animal Diseases (5 papers). Lois La Grenade is often cited by papers focused on T-cell and Retrovirus Studies (5 papers), Drug-Induced Adverse Reactions (5 papers) and Vector-Borne Animal Diseases (5 papers). Lois La Grenade collaborates with scholars based in United States, Jamaica and United Kingdom. Lois La Grenade's co-authors include Angela Manns, Michie Hisada, Steven J. Lemery, Jeffrey Siegel, Lauren Choi, Ann McMahon, David J. Graham, Richard Platt, Claudia B. Karwoski and K. Arnold Chan and has published in prestigious journals such as The Lancet, JAMA and PEDIATRICS.

In The Last Decade

Lois La Grenade

18 papers receiving 904 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lois La Grenade United States	12	462	278	254	139	133	20	937
Eli Geva Israel	25	553 1.2×	77 0.3×	2 0.0×	109 0.8×	40 0.3×	52	2.0k
Seiko Kato Japan	14	142 0.3×	14 0.1×	12 0.0×	68 0.5×	24 0.2×	80	691
Kunihiko Murase Japan	15	153 0.3×	10 0.0×	9 0.0×	382 2.7×	16 0.1×	52	1.0k
S. Agrawal India	17	572 1.2×	93 0.3×	4 0.0×	72 0.5×	21 0.2×	46	957
Simone D. Holligan Canada	9	152 0.3×	56 0.2×	2 0.0×	48 0.3×	18 0.1×	19	809
Saliou Diop Senegal	15	53 0.1×	27 0.1×	22 0.1×	20 0.1×	6 0.0×	108	749
P Segond France	9	129 0.3×	11 0.0×	7 0.0×	146 1.1×	21 0.2×	23	449
E. Sanna Italy	11	57 0.1×	24 0.1×	9 0.0×	51 0.4×	6 0.0×	38	433
Hongmei Wang China	14	44 0.1×	14 0.1×	12 0.0×	91 0.7×	17 0.1×	69	592
Graham Wetherill United States	10	92 0.2×	41 0.1×	2 0.0×	19 0.1×	8 0.1×	27	344

Countries citing papers authored by Lois La Grenade

Since Specialization

Citations

This map shows the geographic impact of Lois La Grenade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lois La Grenade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lois La Grenade more than expected).

Fields of papers citing papers by Lois La Grenade

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lois La Grenade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lois La Grenade. The network helps show where Lois La Grenade may publish in the future.

Co-authorship network of co-authors of Lois La Grenade

This figure shows the co-authorship network connecting the top 25 collaborators of Lois La Grenade. A scholar is included among the top collaborators of Lois La Grenade based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lois La Grenade. Lois La Grenade is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Horgan, Casie, Efe Eworuke, Elizabeth Dee, et al.. (2020). Complementary Use of U.S. FDA’s Adverse Event Reporting System and Sentinel System to Characterize Direct Oral Anticoagulants‐Associated Cutaneous Small Vessel Vasculitis. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 40(11). 1099–1107. 8 indexed citations

Grenade, Lois La, et al.. (2019). Pruritus after discontinuation of cetirizine. Therapeutic Advances in Drug Safety. 10. 584401948–584401948. 4 indexed citations

Grenade, Lois La, et al.. (2017). Acute Generalized Exanthematous Pustulosis in Association with Hydroxyzine and Cetirizine. SKIN The Journal of Cutaneous Medicine. 1(3). 112–116.

Grenade, Lois La, et al.. (2016). Chemical Leukoderma Associated with Methylphenidate Transdermal System: Data From the US Food and Drug Administration Adverse Event Reporting System. The Journal of Pediatrics. 180. 241–246. 6 indexed citations

Pirmohamed, Munir, Peter S. Friedmann, Mariam Molokhia, et al.. (2011). Phenotype Standardization for Immune-Mediated Drug-Induced Skin Injury. Clinical Pharmacology & Therapeutics. 89(6). 896–901. 84 indexed citations

Siegel, Jeffrey, et al.. (2010). Tumor necrosis factor α blockers and malignancy in children: Forty‐eight cases reported to the food and drug administration. Arthritis & Rheumatism. 62(8). 2517–2524. 175 indexed citations

Weaver, Joyce, et al.. (2009). Finding, evaluating, and managing drug-related risks: approaches taken by the US Food and Drug Administration (FDA). Dermatologic Therapy. 22(3). 204–215. 13 indexed citations

Schech, Stephanie D., David J. Graham, Judy A. Staffa, et al.. (2006). Risk factors for statin‐associated rhabdomyolysis. Pharmacoepidemiology and Drug Safety. 16(3). 352–358. 96 indexed citations

Grenade, Lois La, Lauren Lee, Joyce Weaver, et al.. (2005). Comparison of Reporting of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Association with Selective COX-2 Inhibitors. Drug Safety. 28(10). 917–924. 59 indexed citations

10.

Andrade, Susan E., David J. Graham, Judy A. Staffa, et al.. (2005). Health plan administrative databases can efficiently identify serious myopathy and rhabdomyolysis. Journal of Clinical Epidemiology. 58(2). 171–174. 39 indexed citations

11.

Graham, David J., Judy A. Staffa, Lois La Grenade, et al.. (2005). Rhabdomyolysis and Lipid-Lowering Drugs—Reply. JAMA. 293(12). 1448–1448.

12.

Bonnel, Renan A., Lois La Grenade, Claudia B. Karwoski, & Julie Beitz. (2003). Allergic contact dermatitis from topical doxepin: Food and Drug Administration's postmarketing surveillance experience. Journal of the American Academy of Dermatology. 48(2). 294–296. 20 indexed citations

13.

Grenade, Lois La, David J. Graham, & Parivash Nourjah. (2001). Underreporting of Hemorrhagic Stroke Associated With Phenylpropanolamine. JAMA. 286(24). 3081–3081. 14 indexed citations

14.

Grenade, Lois La, et al.. (2000). Adverse Effects of Lotrisone Cream Used in Infants. PEDIATRICS. 106(6). 1519–1519. 1 indexed citations

15.

Manns, Angela, Michie Hisada, & Lois La Grenade. (1999). Human T-lymphotropic virus type I infection. The Lancet. 353(9168). 1951–1958. 261 indexed citations

16.

Grenade, Lois La, Angela Manns, B Hanchard, et al.. (1998). Clinical, Pathologic, and Immunologic Features of Human T-Lymphotrophic Virus Type I–Associated Infective Dermatitis in Children. Archives of Dermatology. 134(4). 439–439. 98 indexed citations

17.

Grenade, Lois La. (1996). HTLV-I-Associated Infective Dermatitis: Past, Present, and Future. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 13. S46–S49. 35 indexed citations

18.

Grenade, Lois La, Robert A. Schwartz, & C K Janniger. (1996). Childhood dermatitis in the tropics: with special emphasis on infective dermatitis, a marker for infection with human T-cell leukemia virus-I.. PubMed. 58(2). 115–8. 18 indexed citations

19.

Grenade, Lois La. (1994). HTLV-I, infective dermatitis, and tropical spastic paraparesis. Molecular Neurobiology. 8(2-3). 147–148. 5 indexed citations

20.

Grenade, Lois La, et al.. (1980). Skin disease at the University Hospital of the West Indies (1970-1975) - abstract. West Indian Medical Journal. 222–222. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact